J Korean Med Assoc.  2006 Apr;49(4):369-373. 10.5124/jkma.2006.49.4.369.

Management of Recurrent Pregnancy Loss

• Kwak IP

• KMID: 1958291
• DOI: http://doi.org/10.5124/jkma.2006.49.4.369

Abstract

Recurrent pregnancy loss (RPL) is defined as three or more consecutive spontaneous abortions. It affects about 1% of couples attempting pregnancy. Most of these pregnancy losses are unrecognized. Among the pregnancies that are clinically recognized, loss occurs in 15% before 20 weeks of gestation. Only about 50% of women with RPL have an identifiable etiology. Genetic abnormalities are responsible for RPL in 2~4% of these couples, most with balanced translocation. Luteal phase defect might be present in 25~30% of women with RPL; however, progesterone supplementation for miscarriage prevention has not been adequately studied. Uterine abnormalities might also result in RPL. Inherited thrombophilias appear to be associated with fetal death, and antenatal thromboprophylaxis might be beneficial for some women with an inherited thrombophilia. Antiphospholipid syndrome is known to cause RPL, and antenatal thromboprophylaxis reduces the risk of miscarriage. The evidence on alloimmune incompatibility as a cause of RPL is preliminary and no immunotherapy has been shown to be effective in the prevention of miscarriage. Recently a series of new factors that exhibit an association with RPL have been identified, and they might exhibit an additive or multiplicative effect on the RPL risk.

Keyword

Recurrent pregnancy loss; Spontaneous abortion; Miscarriage; Fetal death

MeSH Terms

Abortion, Spontaneous
Antiphospholipid Syndrome
Family Characteristics
Female
Fetal Death
Humans
Immunotherapy
Luteal Phase
Pregnancy*
Progesterone
Thrombophilia
Progesterone

Reference

1. Dosiou C, Giudice LC. Natural Killer cells in pregnancy and recurrent pregnancy loss: Endocrine and immunologic perspectives. Endocinereviews. 2005. 26:44–62.

2. Wilcox AJ, Weinberg CR, O'Connor JF, Baired DD, Schlatterer JP, Nisula BC, et al. Incidence of early loss of pregnancy. N Engl J Me. 1988. 319:189–194.

3. Glodstein SR. Enbryonic death in early pregnancy: a new look at the first trimester. Obstet Gynecol. 1994. 84:294–297.

4. Daniel A, Hook EB, Wulf G. Risks of unbalanced progeny at amniocentesis to carriers of chromosome rearrangement. Am J Med Genet. 1989. 33:14–53.

5. Vidal F, Gimenez C, Rubrio C, Simon C, Pellicer A, Egozcue J, et al. FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastage. J Assist Reprod Gene. 1998. 15:310–313.

6. Sullivan AE, Silver RM, La Coursiere DY, Porter TF, Branch DW. Recurrent fetal aneuploidy and recurrent miscarriage. obstet Gynecol. 2004. 104:784–788.

7. Proctor JA, Haney AF. Recurrent 1st trimester pregnancy loss is associated with uterine septum but not with bicorunate uterus. Fertil steril. 2003. 80:1212–1215.

8. Christiansen OB, Anderson AN, Bosch E, Daya S, Delves PJ, van der ven K, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005. 83:821–839.

9. Schust DJ, Hill JA. Reccurent pregnancy loss. Novak's Gynecology 13th ed. 2002. Lippincott Williams & Wilkins;1067–1107.

10. Christiansen OB, Nilson HS, Pederson B. Active or passive immunization in unexplained recurrent miscarriage. J Reprod Immunol. 2004. 62:41–52.